| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 52033-74-6 | 硫酸苯肼; 苯肼硫酸鹽 | Phenylhydrazine sulfate |  | (C6H8N2)2.H2SO4;C12H18N4O4S | 詳情 | 供應(yīng)商 |
| 66472-86-4 | 3-氨基苯硼酸半硫酸鹽; 間氨基苯硼酸半硫酸鹽 | 3-Aminobenzeneboronic acid hemisulfate salt |  | 2(C6H8BNO2).H2SO4 | 詳情 | 供應(yīng)商 |
| 96946-42-8 | 順苯磺阿曲庫(kù)銨; 順苯阿曲庫(kù)銨; (1R,1'R,2R,2'R)-2,2'-[1,5-戊二基雙[氧(3-氧-3,1-丙二基)]]雙[1-(3,4-二甲氧 | Cisatracurium besylate; (1R,1'R,2R,2'R)-2,2'-[1,5-Pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-isoquinolinium dibenzenesulfonate; Cisatracurium besi |  | C53H72N2O12.2(C6H5O3S);C65H82N2O18S2 | 詳情 | 供應(yīng)商 |
| 72207-77-3 | 重氮化-5-氨基-2-(苯氨基)磺酸鈉; 4-[(2-羥基-3,5-二硝基苯基)偶氮]-1,3-苯二酚; 重氮化-4-硝基苯胺; 重氮化-3 | iron, complexes with diazotized 5-amino-2-(phenylamino)benzenesulfonic acid mon; osodium salt coupled with 4-[(2-hydroxy-3,5-dinitrophenyl)azo]-1,3-benzenediol,; diazotized 4-nitrobenzenamine and diazotized 3-aminobenzenesulfonic acid monos | 無(wú) | C12H12N2O3S.C12H8N4O7.C6H7NO3S.C6H6N2O2.Fe.2Na | 詳情 | 供應(yīng)商 |
| 125562-53-0 | 甲基-13C苯基砜 | Benzene,(methyl-13C-sulfonyl)-; METHYL-13C PHENYL SULFONE; METHYL-13C PHENYL SULFONE, 99 ATOM % 13C |  | C6(13C)H8O2S | 詳情 | 供應(yīng)商 |
| 102629-88-9 | Bleomycinamide,3B-O-de(aminocarbonyl)-N1-[3-[(1-phenylethyl)amino]propyl]-, (S)- (9CI); Deamidepeplomycin |  | C60H87N17O20S2 | 詳情 | 供應(yīng)商 | |
| 49745-27-9 | Bradykinin,N2-[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]- (9CI); Dansylbradykinin |  | C62H84N16O13S | 詳情 | 供應(yīng)商 | |
| 110880-53-0 | Neurokinin B (swinespinal cord), 7-(N-methyl-L-phenylalanine)- (9CI); L-Methioninamide,L-a-aspartyl-L-methionyl-L-histidyl-L-a-aspartyl-L-phenylalanyl-L-phenylalanyl-N-methyl-L-phenylalanylglycyl-L-leucyl-; [MePhe7]-Neurokinin B; [MePhenylalanine7]-Neurokinin B |  | C60H81N13O14S2 | 詳情 | 供應(yīng)商 | |
| 68247-85-8 | 培洛霉素; 苯乙丙雙胺博萊霉素；匹來(lái)霉素；派來(lái)霉素 | peplomycin; NK-631；PEP；PLM；PEP-Bleomycin；pepleocine；pepleomycin；peplocin；pepreomycm；pelomecin sulfate；pepleo injection |  | C61H88N18O21S2 | 詳情 | 供應(yīng)商 |
| 125131-58-0 | Perisulfakinin (9CI); LeucosulfakininI, 4-L-aspartic acid-; L-Phenylalaninamide, L-a-glutamyl-L-glutaminyl-L-phenylalanyl-L-a-aspartyl-L-a-aspartyl-O-sulfo-L-tyrosylglycyl-L-histidyl-L-methionyl-L-arginyl-; PSK; Perisulfakinin I |  | C64H86N18O22S2 | 詳情 | 供應(yīng)商 | |
| 154975-39-0 | 四[1-[(4-叔丁基苯基)磺酰]-(2S)-吡咯烷羧酸]二銠(II) | Rhodium, tetrakis[m-[1-[[4-(1,1-dimethylethyl)phenyl]sulfonyl]-L-prolinato-kO2:kO2']]di-, (Rh-Rh); Rhodium,tetrakis[m-[1-[[4-(1,1-dimethylethyl)phenyl]sulfonyl]-L-prolinato-O2:O2']]di-,(Rh-Rh) |  | C60H80N4O16Rh2S4 | 詳情 | 供應(yīng)商 |
| 29451-71-6 | Ranatensin (8CI,9CI); 5-Oxo-L-prolyl-L-valyl-L-prolyl-L-glutaminyl-L-tryptophyl-L-alanyl-L-valylglycyl-L-histidyl-L-phenylalanyl-L-methioninamide; L-Methioninamide,5-oxo-L-prolyl-L-valyl-L-prolyl-L-glutaminyl-L-tryptophyl-L-alanyl-L-valylglycyl-L-histidyl-L-phenylalanyl- |  | C61H84N16O13S | 詳情 | 供應(yīng)商 | |
| 81643-78-9 | Urotensin II(Gillichthys mirabilis reduced) (9CI); 1: PN:US20040121343 PAGE: 31 unclaimed sequence; 31: PN: WO0031265 FIGURE: 6unclaimed sequence; 35: PN: WO2004045592 SEQID: 35 unclaimed sequence; 3: PN:US6159700 SEQID: 3 claimed sequence; 6: PN: WO0114888 SEQID: 4 unclaimedsequence; 77: PN: US20090175821 SEQID: 99 claimed protein; 7: PN: US20050255484SEQID: 7 unclaimed sequence; 7: PN: WO2004037863 SEQID: 6 claimed sequence; 96:PN: WO0069900 SEQID: 99 unclaimed sequence; L-Valine,N-[N-[N-[N2-[N-[N-[N-[N-[N-[N-(N-L-alanylglycyl)-L-threonyl]-L-alanyl]-L-a-aspartyl]-L-cysteinyl]-L-phenylalanyl]-L-tryptophyl]-L-lysyl]-L-tyrosyl]-L-cysteinyl]- |  | C62H86N14O17S2 | 詳情 | 供應(yīng)商 | |
| 9047-55-6 | Urotensin II(Gillichthys mirabilis) (8CI,9CI); 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane,cyclic peptide deriv.; 8: PN: JP2002087982 PAGE: 2 claimed protein; Gillichthysmirabilis urotensin II; Urotensin II (Gillichthys mirabilis reduced), cyclic (6® 11)-disulfide; Urotensin II(goby) |  | C62H84N14O17S2 | 詳情 | 供應(yīng)商 | |
| 183800-15-9 | Tetrakis[1-[(4-tert-butylphenyl)sulfonyl]-(2R)-pyrrolidinecarboxylate]dirhodium(II) |  | C60H80N4O16Rh2S4 | 詳情 | 供應(yīng)商 | |
| 15671-27-9 | sulphitocobalamin; sulphitocobalamin; Hydroxocobalamin Sulphate; sulfitocobalamin | 無(wú) | C62H89CoN13O17PS | 詳情 | 供應(yīng)商 | |
| 145237-46-3 | LEAD IONOPHORE IV; LEAD IONOPHORE IV; TERT-BUTYLCALIX[4]ARENE-TETRAKIS(N,N-DIMETHYLTHIOACETAMIDE) | 無(wú) | C60H84N4O4S4 | 詳情 | 供應(yīng)商 | |
| 74499-03-9 | oxytocin dihydrogen citrate; oxytocin dihydrogen citrate; Oxytocin 2-hydroxy-1,2,3-propanetricarboxylate | 無(wú) | C43H66N12O12S2.C6H8O7 | 詳情 | 供應(yīng)商 | |
| 64790-15-4 | ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR; PHE-VAL-GLN-TRP-LEU-MET-ASN-THR: FVQWLMNT | H-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-OH; ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR; AQDFVQWLMNT; H-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-OH; GLUCAGON (19-29), BOVINE, HUMAN, PORCINE; GLUCAGON (19-29), HUMAN; GLUCAGON (19-29) (HUMAN, BOVINE, PORCINE); glucagon(19-29; Glucagon (19-29) (human, rat, porcine) |  | C61H89N15O18S | 詳情 | 供應(yīng)商 |
| 133628-75-8 | Neocarradecaose-41,3,5,7,9-penta-O-sulfate sodium salt |  | C60H87Na5O61S5 | 詳情 | 供應(yīng)商 | |